Brath, H
Paldánius, P M
Bader, G
Kolaczynski, W M
Nilsson, P M
Article History
Received: 4 January 2016
Revised: 1 April 2016
Accepted: 27 May 2016
First Online: 4 July 2016
Competing interests
: Dr Brath has received honoraria for lectures and advisory boards from all major diabetes companies, including Novartis, but has no specific conflict of interest relevant to the study. Dr Paldánius, Dr Bader and Dr Kolaczynski are employees of Novartis and own stocks of Novartis. Professor Nilsson has received honoraria for advisory boards and lectures from Novartis.